首页 > 最新文献

Chemico-Biological Interactions最新文献

英文 中文
The influence of naturally occurring and in silico-informed mutations of MRP1/ABCC1 on the transport of arsenic triglutathione MRP1/ABCC1天然突变和硅信息突变对砷三谷胱甘肽运输的影响
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-19 DOI: 10.1016/j.cbi.2025.111839
William Li , Yingze Ma , Yuval Bin Kanner , Janet R. Zhou , Assaf Ganoth , Yossi Tsfadia , Elaine M. Leslie
Chronic exposure of humans to arsenic causes skin, bladder, and lung tumors and is associated with multiple non-malignant diseases including atherosclerosis and diabetes mellitus. The multidrug resistance protein 1 (MRP1/gene ABCC1) is an established cellular export pathway for arsenic metabolites including arsenic triglutathione (As(GS)3). Little is known about the relationship between interindividual variation in susceptibility to arsenic-induced diseases and the highly polymorphic ABCC1. Eleven naturally occurring mutants (C43S-, R230Q-, R433S-, R633Q-, G671V-, R723Q-, A989T-, C1047S-, R1058Q-, V1146I-, and S1512L-MRP1) were tested for leukotriene C4 (LTC4, prototypical MRP1 substrate) and As(GS)3 transport using MRP1-enriched vesicles, prepared from human embryonic kidney 293T cells. Mutant-MRP1 levels and LTC4 transport activity were similar to wild-type (WT)-MRP1, except R433S-MRP1 LTC4 transport was reduced by 71 %. As(GS)3 transport by R230Q-, R433S- and A989T-MRP1-enriched membrane vesicles was reduced to 64 ± 9 %, 30 ± 16 %, and 44 ± 33 % of WT-MRP1, respectively. The reduction in R230Q-, R433S-, and A989T-MRP1 As(GS)3 transport activity was due to reduced Vmax values. Computational modeling indicated structural destabilization of these three mutants, and predicted multiple key As(GS)3-binding residues in WT-MRP1. Five of these residues were mutated and tested for As(GS)3 transport activity. As(GS)3 transport by W553A-, R593E-, and W1246A-MRP1 was 34 ± 9 %, 34 ± 13 %, and 48 ± 13 % of WT-MRP1, respectively, while V554A- and E1089Q-MRP1 activity was similar to WT-MRP1. Thus, naturally occurring and in silico informed mutations negatively affect As(GS)3 transport by MRP1. Individuals with R230Q-, R433S-, and A989T-MRP1 mutations may be more susceptible to arsenic-induced diseases.
人体长期接触砷会导致皮肤、膀胱和肺部肿瘤,并与多种非恶性疾病有关,包括动脉粥样硬化和糖尿病。多药耐药蛋白1 (MRP1/基因ABCC1)是砷代谢产物(包括砷甘油三酯(As(GS)3))的细胞出口途径。对砷诱导疾病易感性的个体间差异与高度多态性的ABCC1之间的关系知之甚少。11个天然突变体(C43S-、R230Q-、R433S-、R633Q-、G671V-、R723Q-、A989T-、C1047S-、R1058Q-、V1146I和S1512L-MRP1)利用人胚胎肾293T细胞制备的富含MRP1的囊泡,检测白三烯C4 (LTC4, MRP1的原型底物)和As(GS)3的转运。突变型mrp1的水平和LTC4转运活性与野生型(WT)-MRP1相似,但R433S-MRP1的LTC4转运减少了71%。富含R230Q-、R433S-和a989t - mrp1的膜泡转运As(GS)3分别减少到WT-MRP1的64±9%、30±16%和44±33%。R230Q-、R433S-和A989T-MRP1 As(GS)3转运活性的降低是由于Vmax值的降低。计算模型显示了这三个突变体的结构不稳定,并预测了WT-MRP1中多个关键的As(GS)3结合残基。其中5个残基突变并检测As(GS)3转运活性。W553A-、R593E-和W1246A-MRP1的As(GS)3转运量分别为WT-MRP1的35±9%、34±13%和48±13%,而V554A-和E1089Q-MRP1的活性与WT-MRP1相似。因此,自然发生的和硅通知突变对MRP1的As(GS)3转运产生负面影响。携带R230Q-、R433S-和A989T-MRP1突变的个体可能更容易患砷诱导的疾病。
{"title":"The influence of naturally occurring and in silico-informed mutations of MRP1/ABCC1 on the transport of arsenic triglutathione","authors":"William Li ,&nbsp;Yingze Ma ,&nbsp;Yuval Bin Kanner ,&nbsp;Janet R. Zhou ,&nbsp;Assaf Ganoth ,&nbsp;Yossi Tsfadia ,&nbsp;Elaine M. Leslie","doi":"10.1016/j.cbi.2025.111839","DOIUrl":"10.1016/j.cbi.2025.111839","url":null,"abstract":"<div><div>Chronic exposure of humans to arsenic causes skin, bladder, and lung tumors and is associated with multiple non-malignant diseases including atherosclerosis and diabetes mellitus. The multidrug resistance protein 1 (MRP1/gene <em>ABCC1</em>) is an established cellular export pathway for arsenic metabolites including arsenic triglutathione (As(GS)<sub>3</sub>). Little is known about the relationship between interindividual variation in susceptibility to arsenic-induced diseases and the highly polymorphic <em>ABCC1</em>. Eleven naturally occurring mutants (C43S-, R230Q-, R433S-, R633Q-, G671V-, R723Q-, A989T-, C1047S-, R1058Q-, V1146I-, and S1512L-MRP1) were tested for leukotriene C<sub>4</sub> (LTC<sub>4</sub>, prototypical MRP1 substrate) and As(GS)<sub>3</sub> transport using MRP1-enriched vesicles, prepared from human embryonic kidney 293T cells. Mutant-MRP1 levels and LTC<sub>4</sub> transport activity were similar to wild-type (WT)-MRP1, except R433S-MRP1 LTC<sub>4</sub> transport was reduced by 71 %. As(GS)<sub>3</sub> transport by R230Q-, R433S- and A989T-MRP1-enriched membrane vesicles was reduced to 64 ± 9 %, 30 ± 16 %, and 44 ± 33 % of WT-MRP1, respectively. The reduction in R230Q-, R433S-, and A989T-MRP1 As(GS)<sub>3</sub> transport activity was due to reduced V<sub>max</sub> values. Computational modeling indicated structural destabilization of these three mutants, and predicted multiple key As(GS)<sub>3</sub>-binding residues in WT-MRP1. Five of these residues were mutated and tested for As(GS)<sub>3</sub> transport activity. As(GS)<sub>3</sub> transport by W553A-, R593E-, and W1246A-MRP1 was 34 ± 9 %, 34 ± 13 %, and 48 ± 13 % of WT-MRP1, respectively, while V554A- and E1089Q-MRP1 activity was similar to WT-MRP1. Thus, naturally occurring and <em>in silico</em> informed mutations negatively affect As(GS)<sub>3</sub> transport by MRP1. Individuals with R230Q-, R433S-, and A989T-MRP1 mutations may be more susceptible to arsenic-induced diseases.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111839"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the neurodevelopmental toxicity of graphene oxides using 3D human brain organoids and zebrafish models: emphasis on GABAergic neuron alterations at single-cell resolution 利用三维人脑类器官和斑马鱼模型研究氧化石墨烯的神经发育毒性:强调单细胞分辨率下gaba能神经元的改变。
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-21 DOI: 10.1016/j.cbi.2025.111849
Yuna Chen , Weichao Zhao , Lu Gan , Chaobo Huang , Xudong Liu , Dingxin Long , Yi Cao
Exposure to graphene oxides (GOs) may induce neurotoxic effects, but the mechanisms and extent of these effects remain unclear, partly due to limitations in traditional neurotoxicity models. In this study, we utilized 3D human brain organoids and zebrafish larvae to investigate GO-induced neurodevelopmental toxicity. In 3D human brain organoids, GOs significantly reduced cellular viability in a dose-dependent manner, with bulk RNA-sequencing indicating minimal impact on neuron-related pathways. However, single-cell RNA-sequencing revealed significant alterations in glutamatergic and GABAergic neurons, particularly in gene ontology terms related to synaptic function and neuronal development. Further analysis showed that GO exposure affected the localization, morphology, and electrophysiological activity of GABAergic neurons. Additionally, key genes involved in neurodegeneration (ko05022) and protein processing in endoplasmic reticulum (ko04141) were dysregulated in GABAergic neurons. In vivo studies using zebrafish larvae demonstrated altered locomotor behaviors, including hyperactivity during dark cycles and reduced swimming distances during light cycles, alongside a loss of GABAergic neurons in specific brain regions. These findings highlight the potential neurodevelopmental toxicity of GOs, especially through their impact on GABAergic neurons, and underscore the value of combining 3D human brain organoids and zebrafish models with single-cell resolution techniques to better understand the neurotoxic effects of nanomaterials.
暴露于氧化石墨烯(GOs)可能诱发神经毒性作用,但这些作用的机制和程度尚不清楚,部分原因是传统神经毒性模型的局限性。在这项研究中,我们利用3D人脑类器官和斑马鱼幼虫来研究氧化石墨烯诱导的神经发育毒性。在3D人脑类器官中,GOs以剂量依赖的方式显著降低细胞活力,大量rna测序表明对神经元相关通路的影响最小。然而,单细胞rna测序揭示了谷氨酸能和gaba能神经元的显著变化,特别是在与突触功能和神经元发育相关的基因本体论方面。进一步分析表明,氧化石墨烯暴露会影响gaba能神经元的定位、形态和电生理活动。此外,gaba能神经元中参与神经变性(ko05022)和内质网蛋白加工(ko04141)的关键基因也出现了失调。对斑马鱼幼体的体内研究表明,斑马鱼幼体的运动行为发生了改变,包括在黑暗周期中过度活跃,在光明周期中游泳距离缩短,同时在特定的大脑区域失去gaba能神经元。这些发现强调了go的潜在神经发育毒性,特别是通过它们对gaba能神经元的影响,并强调了将3D人脑类器官和斑马鱼模型与单细胞分辨率技术相结合的价值,以更好地了解纳米材料的神经毒性作用。
{"title":"Investigating the neurodevelopmental toxicity of graphene oxides using 3D human brain organoids and zebrafish models: emphasis on GABAergic neuron alterations at single-cell resolution","authors":"Yuna Chen ,&nbsp;Weichao Zhao ,&nbsp;Lu Gan ,&nbsp;Chaobo Huang ,&nbsp;Xudong Liu ,&nbsp;Dingxin Long ,&nbsp;Yi Cao","doi":"10.1016/j.cbi.2025.111849","DOIUrl":"10.1016/j.cbi.2025.111849","url":null,"abstract":"<div><div>Exposure to graphene oxides (GOs) may induce neurotoxic effects, but the mechanisms and extent of these effects remain unclear, partly due to limitations in traditional neurotoxicity models. In this study, we utilized 3D human brain organoids and zebrafish larvae to investigate GO-induced neurodevelopmental toxicity. In 3D human brain organoids, GOs significantly reduced cellular viability in a dose-dependent manner, with bulk RNA-sequencing indicating minimal impact on neuron-related pathways. However, single-cell RNA-sequencing revealed significant alterations in glutamatergic and GABAergic neurons, particularly in gene ontology terms related to synaptic function and neuronal development. Further analysis showed that GO exposure affected the localization, morphology, and electrophysiological activity of GABAergic neurons. Additionally, key genes involved in neurodegeneration (ko05022) and protein processing in endoplasmic reticulum (ko04141) were dysregulated in GABAergic neurons. <em>In vivo</em> studies using zebrafish larvae demonstrated altered locomotor behaviors, including hyperactivity during dark cycles and reduced swimming distances during light cycles, alongside a loss of GABAergic neurons in specific brain regions. These findings highlight the potential neurodevelopmental toxicity of GOs, especially through their impact on GABAergic neurons, and underscore the value of combining 3D human brain organoids and zebrafish models with single-cell resolution techniques to better understand the neurotoxic effects of nanomaterials.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111849"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145589664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GLS1 inhibitor CB-839 inhibits the malignant progression of 5-FU resistant hepatoma cells by regulating glutamine metabolism GLS1抑制剂CB-839通过调节谷氨酰胺代谢抑制5-FU耐药肝癌细胞的恶性进展。
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-08 DOI: 10.1016/j.cbi.2025.111812
Hao Wang , Xiao-yan Wang , Jian-bo Ji , Zong-xue Zheng , Peng-fei Shang , Xiu-li Guo
Liver cancer, primary hepatocellular carcinoma (HCC), posing a significant threat to human health due to its high prevalence and limited treatment options. As a first-line chemotherapeutic agent for HCC, 5-fluorouracil (5-FU) has demonstrated significant efficacy in suppressing tumor cell proliferation through its cytotoxic mechanisms. Yet, prolonged 5-FU administration often induces chemo-resistant phenotypes in cancer cells, severely compromising the long-term efficacy of 5-FU-based treatment regimens and becoming a major barrier to successful HCC therapy. In this study, we investigated the mechanism underlying 5-FU resistance in Bel7402 hepatoma cells and found that it is closely related to metabolic reprogramming of glutamine. Notably, we demonstrated that CB-839, which is an inhibitor of glutamine metabolism's rate-limiting enzyme (glutaminase), has no notable anti-tumor activity alone but effectively enhances resistant HCC cells' sensitivity to 5-FU both in vitro and in vivo. The mechanism underlying this sensitization involves the disruption of cellular redox homeostasis. Specifically, the combination of CB-839 and 5-FU increases the accumulation of reactive oxygen species (ROS) and induces oxidative stress by consuming intracellular glutathione (GSH) reserves. Furthermore, this combination therapy elevates intracellular Fe2+levels and promotes lipid peroxidation, ultimately triggering ferroptosis. Collectively, these findings tentatively address certain aspects of the unclear mechanism underlying 5-FU resistance in HCC. Specifically, they may suggest targeting glutamine metabolism as a potential avenue for intervention and offer novel perspectives on understanding this resistance. Concurrently, these discoveries provide some support for optimizing chemotherapy regimens, with the aim of surmounting the current clinical challenges in reversing drug resistance.
肝癌,原发性肝细胞癌(HCC),由于其高患病率和有限的治疗选择,对人类健康构成重大威胁。5-氟尿嘧啶(5-FU)作为HCC的一线化疗药物,通过其细胞毒性机制抑制肿瘤细胞增殖的效果显著。然而,长时间的5-FU给药往往会在癌细胞中诱导化疗耐药表型,严重影响基于5-FU治疗方案的长期疗效,并成为成功治疗HCC的主要障碍。在本研究中,我们研究了Bel7402肝癌细胞5-FU耐药的机制,发现其与谷氨酰胺的代谢重编程密切相关。值得注意的是,我们证明了CB-839作为谷氨酰胺代谢限速酶(谷氨酰胺酶)的抑制剂,单独没有显著的抗肿瘤活性,但在体外和体内都有效地增强了耐药HCC细胞对5-FU的敏感性。这种致敏的机制涉及细胞氧化还原稳态的破坏。具体来说,CB-839和5-FU的结合增加了活性氧(ROS)的积累,并通过消耗细胞内谷胱甘肽(GSH)储备诱导氧化应激。此外,这种联合治疗提高细胞内Fe2+水平,促进脂质过氧化,最终引发铁下垂。总的来说,这些发现初步解决了HCC中5-FU耐药机制不明确的某些方面。具体来说,他们可能建议将谷氨酰胺代谢作为潜在的干预途径,并为理解这种耐药性提供新的视角。同时,这些发现为优化化疗方案提供了一些支持,旨在克服当前在逆转耐药方面的临床挑战。
{"title":"GLS1 inhibitor CB-839 inhibits the malignant progression of 5-FU resistant hepatoma cells by regulating glutamine metabolism","authors":"Hao Wang ,&nbsp;Xiao-yan Wang ,&nbsp;Jian-bo Ji ,&nbsp;Zong-xue Zheng ,&nbsp;Peng-fei Shang ,&nbsp;Xiu-li Guo","doi":"10.1016/j.cbi.2025.111812","DOIUrl":"10.1016/j.cbi.2025.111812","url":null,"abstract":"<div><div>Liver cancer, primary hepatocellular carcinoma (HCC), posing a significant threat to human health due to its high prevalence and limited treatment options. As a first-line chemotherapeutic agent for HCC, 5-fluorouracil (5-FU) has demonstrated significant efficacy in suppressing tumor cell proliferation through its cytotoxic mechanisms. Yet, prolonged 5-FU administration often induces chemo-resistant phenotypes in cancer cells, severely compromising the long-term efficacy of 5-FU-based treatment regimens and becoming a major barrier to successful HCC therapy. In this study, we investigated the mechanism underlying 5-FU resistance in Bel7402 hepatoma cells and found that it is closely related to metabolic reprogramming of glutamine. Notably, we demonstrated that CB-839, which is an inhibitor of glutamine metabolism's rate-limiting enzyme (glutaminase), has no notable anti-tumor activity alone but effectively enhances resistant HCC cells' sensitivity to 5-FU both in vitro and in vivo. The mechanism underlying this sensitization involves the disruption of cellular redox homeostasis. Specifically, the combination of CB-839 and 5-FU increases the accumulation of reactive oxygen species (ROS) and induces oxidative stress by consuming intracellular glutathione (GSH) reserves. Furthermore, this combination therapy elevates intracellular Fe<sup>2+</sup>levels and promotes lipid peroxidation, ultimately triggering ferroptosis. Collectively, these findings tentatively address certain aspects of the unclear mechanism underlying 5-FU resistance in HCC. Specifically, they may suggest targeting glutamine metabolism as a potential avenue for intervention and offer novel perspectives on understanding this resistance. Concurrently, these discoveries provide some support for optimizing chemotherapy regimens, with the aim of surmounting the current clinical challenges in reversing drug resistance.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111812"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145491176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JUN activation by disrupted calcium homeostasis orchestrates a Nox4–inflammasome–PUMA apoptotic triad in obesity-exacerbated renal injury following lower limb ischaemia–reperfusion 在肥胖加重的下肢缺血再灌注后肾损伤中,钙稳态被破坏导致的JUN激活协调了nox4 -炎性体- puma凋亡三联体
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-13 DOI: 10.1016/j.cbi.2025.111828
Xiaochen Wang , Rui Li , Yuanbing You , Yidi Gao , Tiantian Wang , Jingkang Li , Qiong Zhang
Obesity exacerbates renal injury following lower limb ischaemia–reperfusion (LLIRI) through mechanisms involving calcium dysregulation and oxidative-inflammatory-apoptotic cascades. However, the underlying pathways remain to be identified. Thus, this study aimed to elucidate the underlying pathways by using transcriptomics, multi-omics, and pharmacological validation. Utilizing transcriptomics, multi-omics analysis, and targeted biochemical/molecular assays in a high-fat diet-induced obese mouse model of LLIRI, combined with pharmacological validation using nicardipine in human renal tubular cells exposed to oxidative stress, we elucidated the underlying pathways linking calcium dysregulation to renal injury. In high-fat diet-induced obese mice, LLIRI triggered profound renal transcriptomic reprogramming, with 1530 differentially expressed genes significantly enriched in calcium homeostasis disruption (GO:0055074), NF-κB signalling (KEGG:mmu04064), and apoptosis. Mechanistically, LLIRI-induced surge in reactive oxygen species promoted renal calcium influx by downregulating calcium efflux transporters Atp2b4 (PMCA4) and Kcnma1 (BK channel), which led to Ca2+ overload. This results in activation of the transcription hub JUN, which orchestrated a triad of injury: oxidative stress, as evidenced by Nox4 upregulation and ATP/NAD+ depletion, which elevated lipid (MDA↑), protein (carbonyls↑), and DNA (8-OHdG↑, γ-H2AX↑) damage; inflammation, as evidenced by tumour necrosis factor-α/interleukin (IL)-1β/IL-18 elevation and macrophage infiltration (F4/80+/HMGB1+); and apoptosis, as evidenced by PUMA (Bbc3) induction, caspase-3/8 activation, and Bax/Bcl-2 imbalance. In vitro, H2O2-induced oxidative stress in human renal tubules replicated Ca2+ overload and JUN-driven apoptosis/senescence. Treatment with the L-type calcium channel blocker nicardipine (2.5 μM) attenuated calcium influx, suppressed JUN/Nox4/PUMA expression, reduced caspase activation, and mitigated cellular damage. Our findings establish Ca2+ overload-JUN activation as a central axis integrating oxidative, inflammatory, and apoptotic networks in obesity-aggravated LLIRI renal injury. Integrating multi-omics and pharmacological evidence, we identify JUN as a master transcriptional regulator of the Nox4-inflammasome-PUMA apoptotic triad, thereby elucidating a previously unrecognized pathogenic pathway in obesity-exacerbated renal LLIRI. Targeting this axis with calcium channel blockers is a promising therapeutic strategy.
肥胖通过涉及钙失调和氧化-炎症-凋亡级联反应的机制加重下肢缺血-再灌注(LLIRI)后的肾损伤。然而,潜在的途径仍有待确定。因此,本研究旨在通过转录组学、多组学和药理学验证来阐明潜在的途径。利用转录组学、多组学分析和靶向生化/分子分析在高脂肪饮食诱导的肥胖小鼠LLIRI模型中,结合nicardipine对暴露于氧化应激的人肾小管细胞的药理学验证,我们阐明了钙失调与肾损伤之间的潜在途径。在高脂肪饮食诱导的肥胖小鼠中,LLIRI引发了肾脏转录组重编程,1530个差异表达基因显著富集于钙稳态破坏(GO:0055074)、NF-κB信号传导(KEGG:mmu04064)和细胞凋亡。在机制上,lili诱导的活性氧激增通过下调钙外排转运蛋白Atp2b4 (PMCA4)和Kcnma1 (BK通道)来促进肾钙内流,从而导致Ca2+过载。这导致了转录中枢JUN的激活,这导致了三种损伤:氧化应激,如Nox4上调和ATP/NAD+耗尽所证明的那样,这会导致脂质(MDA↑)、蛋白质(羰基↑)和DNA (8-OHdG↑,γ-H2AX↑)损伤升高;炎症,肿瘤坏死因子-α/白细胞介素(IL)-1β/IL-18升高和巨噬细胞浸润(F4/80+/HMGB1+);PUMA (Bbc3)的诱导、caspase-3/8的激活和Bax/Bcl-2失衡证明了这一点。在体外,h2o2诱导的人肾小管氧化应激复制Ca2+超载和jun驱动的细胞凋亡/衰老。l型钙通道阻滞剂nicardipine (2.5 μM)可减弱钙内流,抑制JUN/Nox4/PUMA表达,降低caspase激活,减轻细胞损伤。我们的研究结果表明,在肥胖加重的LLIRI肾损伤中,Ca2+超载jun激活是一个整合氧化、炎症和凋亡网络的中心轴。综合多组学和药理学证据,我们确定JUN是Nox4-inflammasome-PUMA凋亡三联体的主要转录调节因子,从而阐明了肥胖加重肾LLIRI的一个以前未被认识的致病途径。用钙通道阻滞剂靶向这一轴是一种很有前景的治疗策略。
{"title":"JUN activation by disrupted calcium homeostasis orchestrates a Nox4–inflammasome–PUMA apoptotic triad in obesity-exacerbated renal injury following lower limb ischaemia–reperfusion","authors":"Xiaochen Wang ,&nbsp;Rui Li ,&nbsp;Yuanbing You ,&nbsp;Yidi Gao ,&nbsp;Tiantian Wang ,&nbsp;Jingkang Li ,&nbsp;Qiong Zhang","doi":"10.1016/j.cbi.2025.111828","DOIUrl":"10.1016/j.cbi.2025.111828","url":null,"abstract":"<div><div>Obesity exacerbates renal injury following lower limb ischaemia–reperfusion (LLIRI) through mechanisms involving calcium dysregulation and oxidative-inflammatory-apoptotic cascades. However, the underlying pathways remain to be identified. Thus, this study aimed to elucidate the underlying pathways by using transcriptomics, multi-omics, and pharmacological validation. Utilizing transcriptomics, multi-omics analysis, and targeted biochemical/molecular assays in a high-fat diet-induced obese mouse model of LLIRI, combined with pharmacological validation using nicardipine in human renal tubular cells exposed to oxidative stress, we elucidated the underlying pathways linking calcium dysregulation to renal injury. In high-fat diet-induced obese mice, LLIRI triggered profound renal transcriptomic reprogramming, with 1530 differentially expressed genes significantly enriched in calcium homeostasis disruption (GO:0055074), NF-κB signalling (KEGG:mmu04064), and apoptosis. Mechanistically, LLIRI-induced surge in reactive oxygen species promoted renal calcium influx by downregulating calcium efflux transporters Atp2b4 (PMCA4) and Kcnma1 (BK channel), which led to Ca<sup>2+</sup> overload. This results in activation of the transcription hub JUN, which orchestrated a triad of injury: oxidative stress, as evidenced by Nox4 upregulation and ATP/NAD<sup>+</sup> depletion, which elevated lipid (MDA↑), protein (carbonyls↑), and DNA (8-OHdG↑, γ-H<sub>2</sub>AX↑) damage; inflammation, as evidenced by tumour necrosis factor-α/interleukin (IL)-1β/IL-18 elevation and macrophage infiltration (F4/80<sup>+</sup>/HMGB1<sup>+</sup>); and apoptosis, as evidenced by PUMA (Bbc3) induction, caspase-3/8 activation, and Bax/Bcl-2 imbalance. In vitro, H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in human renal tubules replicated Ca<sup>2+</sup> overload and JUN-driven apoptosis/senescence. Treatment with the L-type calcium channel blocker nicardipine (2.5 μM) attenuated calcium influx, suppressed JUN/Nox4/PUMA expression, reduced caspase activation, and mitigated cellular damage. Our findings establish Ca<sup>2+</sup> overload-JUN activation as a central axis integrating oxidative, inflammatory, and apoptotic networks in obesity-aggravated LLIRI renal injury. Integrating multi-omics and pharmacological evidence, we identify JUN as a master transcriptional regulator of the Nox4-inflammasome-PUMA apoptotic triad, thereby elucidating a previously unrecognized pathogenic pathway in obesity-exacerbated renal LLIRI. Targeting this axis with calcium channel blockers is a promising therapeutic strategy.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111828"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145527202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal cell death induced by indirubin-3′-oxime through inhibition of Akt/mTOR axis in lung cancer cells 靛红素-3′-肟通过抑制Akt/mTOR轴诱导肺癌细胞多模式死亡
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-26 DOI: 10.1016/j.cbi.2025.111851
Na Young Kim , Shalini V. Gowda , Kachigere B. Harsha , D.C. Vinay Kumar , Chakrabhavi Dhananjaya Mohan , C.S. Shivakumara , Kanchugarakoppal S. Rangappa , Kwang Seok Ahn
Lung cancer is a major type of malignancy that has contributed to a high mortality rate for many years. Discovering new small molecules with strong cytotoxic effects on lung cancer is crucial for developing new therapies. In this study, we describe the synthesis of a novel triazole-indirubin-3′-oxime derivative (designated as CRM1) and examine its ability to induce distinct forms of cell death, as well as elucidate the cytotoxicity-associated molecular mechanisms in lung cancer cells. CRM1 selectively reduced cell viability in lung cancer cell lines (A549, PC9, and H1299) without significantly affecting the viability of normal lung cells (HEL299). Mechanistic investigations have demonstrated that CRM1 induces paraptosis through the downregulation of Alix and the upregulation of ATF4 and CHOP. This process is associated with disruption of mitochondrial membrane potential, induction of endoplasmic reticulum stress, and accumulation of reactive oxygen species (ROS). CRM1 was observed to induce apoptosis, as indicated by DNA fragmentation, an increase in Sub-G1 cell population, as well as elevated caspase-3 cleavage and Bax expression. CRM1 also promoted autophagy, as evidenced by increased expression of Atg7, phosphorylated Beclin-1, and LC3-II, as well as enhanced autophagosome formation. Pharmacological inhibition studies confirmed the independent induction of apoptosis, paraptosis, and autophagy. Pre-exposure of cancer cells to N-acetyl cysteine abrogated CRM1-induced cytotoxicity. Mechanistic studies demonstrated that CRM1 suppresses the activation of Akt, mTOR, and p70S6K, while the overexpression of Akt counteracts the CRM1-driven cytotoxic effects. CRM1 also synergistically potentiated the cytotoxic efficacy of paclitaxel by co-targeting multiple cell death processes. Collectively, these results suggest CRM1 as a promising cytotoxic candidate with a multimodal mechanism of action in lung cancer cells.
肺癌是一种主要的恶性肿瘤,多年来造成了很高的死亡率。发现对肺癌具有强细胞毒性作用的新小分子对于开发新疗法至关重要。在这项研究中,我们描述了一种新的三唑-靛红素-3 ' -肟衍生物(称为CRM1)的合成,并研究了其诱导不同形式细胞死亡的能力,以及阐明肺癌细胞毒性相关的分子机制。CRM1选择性地降低肺癌细胞系(A549、PC9和H1299)的细胞活力,而不显著影响正常肺细胞(HEL299)的活力。机制研究表明,CRM1通过下调Alix和上调ATF4和CHOP诱导细胞凋亡。这一过程与线粒体膜电位的破坏、内质网应激的诱导和活性氧(ROS)的积累有关。观察到CRM1诱导细胞凋亡,如DNA断裂,亚g1细胞群增加,以及caspase-3切割和Bax表达升高。CRM1也促进自噬,Atg7、磷酸化Beclin-1和LC3-II的表达增加,自噬体形成增强。药理抑制研究证实了细胞凋亡、细胞凋亡和自噬的独立诱导。将癌细胞预先暴露于n -乙酰半胱氨酸可消除crm1诱导的细胞毒性。机制研究表明,CRM1抑制Akt、mTOR和p70S6K的激活,而Akt的过表达抵消了CRM1驱动的细胞毒性作用。CRM1还通过共同靶向多个细胞死亡过程协同增强紫杉醇的细胞毒性作用。总的来说,这些结果表明,CRM1在肺癌细胞中具有多模态作用机制,是一种有希望的细胞毒性候选者。
{"title":"Multimodal cell death induced by indirubin-3′-oxime through inhibition of Akt/mTOR axis in lung cancer cells","authors":"Na Young Kim ,&nbsp;Shalini V. Gowda ,&nbsp;Kachigere B. Harsha ,&nbsp;D.C. Vinay Kumar ,&nbsp;Chakrabhavi Dhananjaya Mohan ,&nbsp;C.S. Shivakumara ,&nbsp;Kanchugarakoppal S. Rangappa ,&nbsp;Kwang Seok Ahn","doi":"10.1016/j.cbi.2025.111851","DOIUrl":"10.1016/j.cbi.2025.111851","url":null,"abstract":"<div><div>Lung cancer is a major type of malignancy that has contributed to a high mortality rate for many years. Discovering new small molecules with strong cytotoxic effects on lung cancer is crucial for developing new therapies. In this study, we describe the synthesis of a novel triazole-indirubin-3′-oxime derivative (designated as CRM1) and examine its ability to induce distinct forms of cell death, as well as elucidate the cytotoxicity-associated molecular mechanisms in lung cancer cells. CRM1 selectively reduced cell viability in lung cancer cell lines (A549, PC9, and H1299) without significantly affecting the viability of normal lung cells (HEL299). Mechanistic investigations have demonstrated that CRM1 induces paraptosis through the downregulation of Alix and the upregulation of ATF4 and CHOP. This process is associated with disruption of mitochondrial membrane potential, induction of endoplasmic reticulum stress, and accumulation of reactive oxygen species (ROS). CRM1 was observed to induce apoptosis, as indicated by DNA fragmentation, an increase in Sub-G1 cell population, as well as elevated caspase-3 cleavage and Bax expression. CRM1 also promoted autophagy, as evidenced by increased expression of Atg7, phosphorylated Beclin-1, and LC3-II, as well as enhanced autophagosome formation. Pharmacological inhibition studies confirmed the independent induction of apoptosis, paraptosis, and autophagy. Pre-exposure of cancer cells to N-acetyl cysteine abrogated CRM1-induced cytotoxicity. Mechanistic studies demonstrated that CRM1 suppresses the activation of Akt, mTOR, and p70S6K, while the overexpression of Akt counteracts the CRM1-driven cytotoxic effects. CRM1 also synergistically potentiated the cytotoxic efficacy of paclitaxel by co-targeting multiple cell death processes. Collectively, these results suggest CRM1 as a promising cytotoxic candidate with a multimodal mechanism of action in lung cancer cells.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111851"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145621067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platinum(IV) oxaliplatin analog containing axial benzoate ligands induces mitochondrial hyperpolarization and caspase-dependent apoptosis in pancreatic cancer cell models 含轴向苯甲酸配体的铂(IV)奥沙利铂类似物在胰腺癌细胞模型中诱导线粒体超极化和caspase依赖性凋亡
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-03 DOI: 10.1016/j.cbi.2025.111792
Michal Berecka , Jitka Pracharova , Nicola Margiotta , Alessandra Barbanente , Nicoletta Ditaranto , Jana Kasparkova , Viktor Brabec
This study investigates the molecular mechanisms underlying the antiproliferative effects of the platinum(IV) complex trans-[Pt(OBz)2(O,C-10-BzODA)(1R,2R-DACH)] (complex 1; OBz = benzoate, 10-BzODA = 10-benzoyloxy-2-decenoate, DACH = diaminocyclohexane) in pancreatic cancer cell models. Initial findings revealed that complex 1 exhibits substantial antiproliferative activity, positioning it as a promising therapeutic agent for pancreatic cancer, where effective treatment options remain limited. Notably, complex 1 demonstrates significantly greater efficacy compared to platinum(II) drugs, such as cisplatin and oxaliplatin, with IC50 values in the low micromolar range across various pancreatic cancer cell lines. Mechanistic studies suggest that complex 1's enhanced activity is attributed to the axial benzoate ligands, which differentiate it from its platinum(II) analog. Complex 1 accumulates intracellular platinum without undergoing reduction in the extracellular environment, and it induces mitochondrial hyperpolarization. This effect is reminiscent of free sodium benzoate but occurs at a much lower extracellular concentration, indicating the crucial role of the benzoate ligands in modulating mitochondrial function. Furthermore, complex 1 triggers caspase-dependent apoptosis in cancer cells and is also effective in 3D tumor cell models, highlighting its potential as an effective anticancer agent. Thus, this work presents a Pt(IV) prodrug bearing benzoate axial ligands that exhibit distinctive chemical and biological behavior compared with previously reported Pt(IV) prodrugs.
In conclusion, the unique properties of complex 1, driven by its benzoate ligands, suggest that Pt(IV) complexes represent a promising approach for the development of targeted chemotherapeutic agents for the treatment of pancreatic cancer.
本研究探讨了铂(IV)配合物反式-[Pt(OBz)2(O,C-10-BzODA)(1R,2R-DACH)](配合物1;OBz =苯甲酸酯,10-BzODA = 10-苯甲酰氧基-2-十烯酸,DACH =二氨基环己烷)在胰腺癌细胞模型中抗增殖作用的分子机制。初步研究结果显示,复合物1具有显著的抗增殖活性,使其成为一种有前景的治疗胰腺癌的药物,而胰腺癌的有效治疗方案仍然有限。值得注意的是,与铂(II)药物(如顺铂和奥沙利铂)相比,复合物1的疗效显著提高,在各种胰腺癌细胞系中的IC50值在低微摩尔范围内。机理研究表明配合物1的活性增强归因于轴向苯甲酸酯配体,这与它的铂(II)类似物不同。复合物1在细胞内积累铂而不经过细胞外环境的还原,并诱导线粒体超极化。这种作用让人想起游离苯甲酸钠,但发生在细胞外浓度低得多,表明苯甲酸钠配体在调节线粒体功能中的关键作用。此外,复合物1在癌细胞中触发caspase依赖性凋亡,并且在3D肿瘤细胞模型中也有效,这突出了其作为有效抗癌药物的潜力。因此,本研究提出了一种含Pt(IV)前药的苯甲酸酯轴向配体,与先前报道的Pt(IV)前药相比,它表现出独特的化学和生物学行为。综上所述,由苯甲酸酯配体驱动的配合物1的独特性质表明,Pt(IV)配合物代表了开发用于治疗胰腺癌的靶向化疗药物的有希望的方法。
{"title":"Platinum(IV) oxaliplatin analog containing axial benzoate ligands induces mitochondrial hyperpolarization and caspase-dependent apoptosis in pancreatic cancer cell models","authors":"Michal Berecka ,&nbsp;Jitka Pracharova ,&nbsp;Nicola Margiotta ,&nbsp;Alessandra Barbanente ,&nbsp;Nicoletta Ditaranto ,&nbsp;Jana Kasparkova ,&nbsp;Viktor Brabec","doi":"10.1016/j.cbi.2025.111792","DOIUrl":"10.1016/j.cbi.2025.111792","url":null,"abstract":"<div><div>This study investigates the molecular mechanisms underlying the antiproliferative effects of the platinum(IV) complex <em>trans</em>-[Pt(OBz)<sub>2</sub>(<em>O,C</em>-10-BzODA)(1<em>R</em>,2<em>R</em>-DACH)] (complex <strong>1</strong>; OBz = benzoate, 10-BzODA = 10-benzoyloxy-2-decenoate, DACH = diaminocyclohexane) in pancreatic cancer cell models. Initial findings revealed that complex <strong>1</strong> exhibits substantial antiproliferative activity, positioning it as a promising therapeutic agent for pancreatic cancer, where effective treatment options remain limited. Notably, complex <strong>1</strong> demonstrates significantly greater efficacy compared to platinum(II) drugs, such as cisplatin and oxaliplatin, with IC<sub>50</sub> values in the low micromolar range across various pancreatic cancer cell lines. Mechanistic studies suggest that complex <strong>1</strong>'s enhanced activity is attributed to the axial benzoate ligands, which differentiate it from its platinum(II) analog. Complex <strong>1</strong> accumulates intracellular platinum without undergoing reduction in the extracellular environment, and it induces mitochondrial hyperpolarization. This effect is reminiscent of free sodium benzoate but occurs at a much lower extracellular concentration, indicating the crucial role of the benzoate ligands in modulating mitochondrial function. Furthermore, complex <strong>1</strong> triggers caspase-dependent apoptosis in cancer cells and is also effective in 3D tumor cell models, highlighting its potential as an effective anticancer agent. Thus, this work presents a Pt(IV) prodrug bearing benzoate axial ligands that exhibit distinctive chemical and biological behavior compared with previously reported Pt(IV) prodrugs.</div><div>In conclusion, the unique properties of complex <strong>1</strong>, driven by its benzoate ligands, suggest that Pt(IV) complexes represent a promising approach for the development of targeted chemotherapeutic agents for the treatment of pancreatic cancer.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111792"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145442417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cigarette smoke exposure diminishes ovarian reserve in mice by regulating granulosa cells redox homeostasis imbalance through Wnt10b-ERβ feedback loop 香烟烟雾暴露通过Wnt10b-ERβ反馈回路调节颗粒细胞氧化还原稳态失衡,从而减少小鼠卵巢储备
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-05 DOI: 10.1016/j.cbi.2025.111811
Fang Li , Mengting Xu , Yanhui Zhao , Ying Wang , Nengyin Hu , Sailing Ji , Jianing Miao , Li Wang , Lili Wang
Oxidative stress induced by cigarette smoke (CS) exposure can cause ovarian follicle damage and diminishes reserve in women. Our previous study showed CS exposure caused premature ovarian insufficiency (POI) in mice through oxidative stress and senescence in granulosa cells (GCs) via suppressing the expression of Wnt10b, GPX1/GPX4 and FDX1. However, their roles and molecular relationships in oxidative stress and senescence in GCs after CS exposure as well as their diagnostic value for POI remains unclear. In this study, we found that CS exposure resulted in increased ROS production, reduced antioxidant function, mitochondrial dysfunction, cell cycle arrest and cellular senescence in GCs. And the levels of GPX4, GPX1, FDX1 and Wnt10b were also reduced in GCs of pre-POI patients. Over-expression of Wnt10b or application of diarylpropionitrile (DPN, an ERβ agonist) could alleviate above phenotypic changes caused by CSE exposure, however, over-expression of FDX1 only could partially alleviate. Additionally, the serum FDX1 levels exhibit an association with POI progression and serum follicle stimulating hormone (FSH) levels, yet its diagnostic potential for POI alone remains limited. Moreover, ChIP results demonstrated a feedback regulatory relationship between Wnt10b and ERβ, and ERβ is involved in regulating the expression of GPX1, GPX4 and FDX1. The current study demonstrated the regulatory role of the Wnt10b-ERβ feedback loop on GCs redox homeostasis. Our findings provide a theoretical basis for revealing the molecular mechanism of reduced ovarian reserve in women induced by CS exposure, and may provide potential new targets and ideas for the early clinical prediction and diagnosis of human POI.
吸烟引起的氧化应激(CS)暴露会导致卵巢卵泡损伤并减少女性的储备。我们之前的研究表明,CS暴露通过抑制Wnt10b、GPX1/GPX4和FDX1的表达,通过氧化应激和颗粒细胞(GCs)衰老导致小鼠卵巢功能不全(POI)。然而,它们在CS暴露后GCs氧化应激和衰老中的作用和分子关系以及它们对POI的诊断价值尚不清楚。在本研究中,我们发现CS暴露导致GCs中ROS生成增加,抗氧化功能降低,线粒体功能障碍,细胞周期阻滞和细胞衰老。poi前期患者GCs中GPX4、GPX1、FDX1、Wnt10b水平也均降低。过表达Wnt10b或应用ERβ激动剂二芳基丙腈(DPN)可缓解CSE暴露引起的上述表型变化,而过表达FDX1仅能部分缓解。此外,血清FDX1水平与POI进展和血清促卵泡激素(FSH)水平相关,但其单独诊断POI的潜力仍然有限。此外,ChIP结果表明Wnt10b与ERβ之间存在反馈调节关系,ERβ参与调节GPX1、GPX4和FDX1的表达。目前的研究证明了Wnt10b-ERβ反馈回路对GCs氧化还原稳态的调节作用。本研究结果为揭示CS暴露导致女性卵巢储备减少的分子机制提供了理论基础,并可能为人类POI的早期临床预测和诊断提供潜在的新靶点和思路。
{"title":"Cigarette smoke exposure diminishes ovarian reserve in mice by regulating granulosa cells redox homeostasis imbalance through Wnt10b-ERβ feedback loop","authors":"Fang Li ,&nbsp;Mengting Xu ,&nbsp;Yanhui Zhao ,&nbsp;Ying Wang ,&nbsp;Nengyin Hu ,&nbsp;Sailing Ji ,&nbsp;Jianing Miao ,&nbsp;Li Wang ,&nbsp;Lili Wang","doi":"10.1016/j.cbi.2025.111811","DOIUrl":"10.1016/j.cbi.2025.111811","url":null,"abstract":"<div><div>Oxidative stress induced by cigarette smoke (CS) exposure can cause ovarian follicle damage and diminishes reserve in women. Our previous study showed CS exposure caused premature ovarian insufficiency (POI) in mice through oxidative stress and senescence in granulosa cells (GCs) via suppressing the expression of Wnt10b, GPX1/GPX4 and FDX1. However, their roles and molecular relationships in oxidative stress and senescence in GCs after CS exposure as well as their diagnostic value for POI remains unclear. In this study, we found that CS exposure resulted in increased ROS production, reduced antioxidant function, mitochondrial dysfunction, cell cycle arrest and cellular senescence in GCs. And the levels of GPX4, GPX1, FDX1 and Wnt10b were also reduced in GCs of pre-POI patients. Over-expression of Wnt10b or application of diarylpropionitrile (DPN, an ERβ agonist) could alleviate above phenotypic changes caused by CSE exposure, however, over-expression of FDX1 only could partially alleviate. Additionally, the serum FDX1 levels exhibit an association with POI progression and serum follicle stimulating hormone (FSH) levels, yet its diagnostic potential for POI alone remains limited. Moreover, ChIP results demonstrated a feedback regulatory relationship between Wnt10b and ERβ, and ERβ is involved in regulating the expression of GPX1, GPX4 and FDX1. The current study demonstrated the regulatory role of the Wnt10b-ERβ feedback loop on GCs redox homeostasis. Our findings provide a theoretical basis for revealing the molecular mechanism of reduced ovarian reserve in women induced by CS exposure, and may provide potential new targets and ideas for the early clinical prediction and diagnosis of human POI.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111811"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145442411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-specific aggressive and emotional behavior in myostatin-deficient mice: Ratio of acylated versus unacylated ghrelin is reduced, but not correlated with butyrylcholinesterase activity level, however parvalbumin expression is lost in the habenular complex 肌抑制素缺乏小鼠的性别特异性攻击和情绪行为:酰化与未酰化胃饥饿素的比例降低,但与丁基胆碱酯酶活性水平无关,然而小蛋白表达在habenular复合体中丢失。
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-07 DOI: 10.1016/j.cbi.2025.111813
Barbara Vernus , Bénédicte Goustard , Béatrice Chabi , Christelle Bertrand-Gaday , Hillary Maillet , Meghan K. Cash , Pierre Delobel , Sylvain Cerda , Mélanie Macart , Anne Bonnieu , Sultan Darvesh , Arnaud Chatonnet
Myostatin plays crucial roles in negative regulation of muscle growth. Inactivation of the myostatin gene results in gross muscle hypertrophy. We observed that myostatin knock-out (myostatin-KO) mice are more aggressive than wild-type (WT) mice. Ghrelin is a hormone produced by cells of the gastrointestinal tract that activates cells in the brain and increases the drive to eat. The level of circulating ghrelin affects anxiety, stress, and aggression. Ghrelin controls expression of myostatin in disease-associated cachexia. Butyrylcholinesterase (BChE) is responsible for the deacylation of ghrelin. BChE knock-out mice show higher level of acylated ghrelin and are more aggressive than WT mice. De-acylation of ghrelin by BChE reduces aggression in mice. We hypothesized that the levels of expression of BChE, ghrelin and myostatin could explain the aggressive behavior of myostatin-myostatin-KO mice. Resident/intruder tests shows that male myostatin-KO mice are more aggressive than WT littermates. Female myostatin-KO mice show much higher spontaneous exercise than female WT and males of both genotypes. Behavioral tests (elevated plus maze and light/dark box) show that myostatin-KO mice present anxious behavior without any change in circulating corticosterone. Myostatin-KO mice have a lower acylated/unacylated ghrelin ratio. Female myostatin-KO mice show lower level of BChE activity compared with WT littermates. Comparison of staining for various neurotransmitter systems involved in behavior showed that the only region where there was a difference between WT and myostatin-KO mice was in the habenular complex which involved in regulation of behavior. Reduced ghrelin levels and loss of parvalbumin neurons of the habenular complex could partly explain the behavior of our model.
肌肉生长抑制素在肌肉生长负调控中起着至关重要的作用。肌肉生长抑制素基因失活导致肌肉肥大。我们观察到肌生长抑制素敲除(myostatin- ko)小鼠比野生型(WT)小鼠更具攻击性。胃饥饿素是一种由胃肠道细胞产生的激素,它能激活大脑细胞,增加食欲。胃饥饿素的循环水平影响焦虑、压力和攻击性。Ghrelin控制疾病相关恶病质中肌生长抑制素的表达。丁基胆碱酯酶(BChE)负责胃饥饿素的去酰化。BChE敲除小鼠显示出更高水平的酰化饥饿素,并且比WT小鼠更具攻击性。BChE对胃饥饿素的去酰化降低了小鼠的攻击性。我们假设BChE、胃饥饿素和肌肉生长抑制素的表达水平可以解释肌肉生长抑制素-肌肉生长抑制素- ko小鼠的攻击行为。驻地/入侵者试验显示雄性肌抑制素- ko小鼠比WT幼崽更具攻击性。雌性肌生成抑制素- ko小鼠比雌性WT和两种基因型的雄性小鼠表现出更高的自发运动。行为学测试(升高+迷宫和光/暗箱)显示肌生成他汀- ko小鼠表现出焦虑行为,而循环皮质酮没有任何变化。肌生长抑制素- ko小鼠的饥饿素酰化/未酰化比例较低。雌性肌生成抑制素- ko小鼠与WT窝鼠相比BChE活性水平较低。对参与行为的各种神经递质系统的染色比较表明,WT和myostatin-KO小鼠之间唯一存在差异的区域是参与行为调节的habenular complex。胃饥饿素水平的降低和小白蛋白神经元的缺失可以部分解释我们模型的行为。
{"title":"Sex-specific aggressive and emotional behavior in myostatin-deficient mice: Ratio of acylated versus unacylated ghrelin is reduced, but not correlated with butyrylcholinesterase activity level, however parvalbumin expression is lost in the habenular complex","authors":"Barbara Vernus ,&nbsp;Bénédicte Goustard ,&nbsp;Béatrice Chabi ,&nbsp;Christelle Bertrand-Gaday ,&nbsp;Hillary Maillet ,&nbsp;Meghan K. Cash ,&nbsp;Pierre Delobel ,&nbsp;Sylvain Cerda ,&nbsp;Mélanie Macart ,&nbsp;Anne Bonnieu ,&nbsp;Sultan Darvesh ,&nbsp;Arnaud Chatonnet","doi":"10.1016/j.cbi.2025.111813","DOIUrl":"10.1016/j.cbi.2025.111813","url":null,"abstract":"<div><div>Myostatin plays crucial roles in negative regulation of muscle growth. Inactivation of the myostatin gene results in gross muscle hypertrophy. We observed that myostatin knock-out (myostatin-KO) mice are more aggressive than wild-type (WT) mice. Ghrelin is a hormone produced by cells of the gastrointestinal tract that activates cells in the brain and increases the drive to eat. The level of circulating ghrelin affects anxiety, stress, and aggression. Ghrelin controls expression of myostatin in disease-associated cachexia. Butyrylcholinesterase (BChE) is responsible for the deacylation of ghrelin. BChE knock-out mice show higher level of acylated ghrelin and are more aggressive than WT mice. De-acylation of ghrelin by BChE reduces aggression in mice. We hypothesized that the levels of expression of BChE, ghrelin and myostatin could explain the aggressive behavior of myostatin-myostatin-KO mice. Resident/intruder tests shows that male myostatin-KO mice are more aggressive than WT littermates. Female myostatin-KO mice show much higher spontaneous exercise than female WT and males of both genotypes. Behavioral tests (elevated plus maze and light/dark box) show that myostatin-KO mice present anxious behavior without any change in circulating corticosterone. Myostatin-KO mice have a lower acylated/unacylated ghrelin ratio. Female myostatin-KO mice show lower level of BChE activity compared with WT littermates. Comparison of staining for various neurotransmitter systems involved in behavior showed that the only region where there was a difference between WT and myostatin-KO mice was in the habenular complex which involved in regulation of behavior. Reduced ghrelin levels and loss of parvalbumin neurons of the habenular complex could partly explain the behavior of our model.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111813"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic inhibitory effects of enzalutamide and its phase I metabolite on UDP-glucuronosyltransferase 1A1 (UGT1A1) and risk prediction of drug-drug interactions 恩杂鲁胺及其I期代谢物对udp -葡萄糖醛酸糖基转移酶1A1 (UGT1A1)的协同抑制作用及药物-药物相互作用的风险预测
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-13 DOI: 10.1016/j.cbi.2025.111829
Tingting Zheng, Hang Yin, Hongna Shan, Lihuan Sun, Lili Jiang, Yong Liu
Enzalutamide (formerly called MDV3100), a second-generation androgen receptor inhibitor primarily used for treating castration-resistant prostate cancer (CRPC), has been shown to regulating UDP-glucuronosyltransferases (UGTs) expression, while its effects on the activity of UGT isoforms remain unclear. This study aimed to systemically investigate the effects of enzalutamide and its phase I metabolite on the UGT activities, and to assess the risk of drug-drug interactions (DDIs) resulting from UGT inhibition. Using high-performance liquid chromatography (HPLC) and enzyme kinetic studies, we evaluated the inhibitory effects of enzalutamide and its main phase I metabolite, N-desmethyl enzalutamide on 12 UGT isoforms and inhibition patterns. Our findings demonstrated that both enzalutamide and its metabolite exhibited potent inhibition against UGT1A1, with evidence of synergistic effects. Enzyme kinetic analysis revealed that both enzalutamide and its metabolite acted as competitive inhibitors of UGT1A1. In vitro-in vivo extrapolation (IVIVE) prediction indicated that concomitant use of enzalutamide with UGT1A1 substrates could induce clinically significant DDIs. Therefore, special caution should be warranted when administering enzalutamide alongside other drugs metabolized by UGT to mitigate potential DDIs.
Enzalutamide(以前称为MDV3100)是一种主要用于治疗去势抵抗性前列腺癌(CRPC)的第二代雄激素受体抑制剂,已被证明可调节udp -葡萄糖醛基转移酶(UGT)的表达,但其对UGT亚型活性的影响尚不清楚。本研究旨在系统研究恩杂鲁胺及其I期代谢物对UGT活性的影响,并评估UGT抑制引起的药物-药物相互作用(ddi)的风险。采用高效液相色谱(HPLC)和酶动力学研究,研究了enzalutamide及其主要I相代谢物n -去甲基enzalutamide对12种UGT亚型的抑制作用和抑制模式。我们的研究结果表明,enzalutamide及其代谢物对UGT1A1均表现出有效的抑制作用,并具有协同效应。酶动力学分析表明,enzalutamide及其代谢物都是UGT1A1的竞争性抑制剂。体外外推(IVIVE)预测表明,同时使用enzalutamide与UGT1A1底物可诱导临床显著的ddi。因此,当enzalutamide与其他由UGT代谢的药物一起使用以减轻潜在的ddi时,应特别小心。
{"title":"Synergistic inhibitory effects of enzalutamide and its phase I metabolite on UDP-glucuronosyltransferase 1A1 (UGT1A1) and risk prediction of drug-drug interactions","authors":"Tingting Zheng,&nbsp;Hang Yin,&nbsp;Hongna Shan,&nbsp;Lihuan Sun,&nbsp;Lili Jiang,&nbsp;Yong Liu","doi":"10.1016/j.cbi.2025.111829","DOIUrl":"10.1016/j.cbi.2025.111829","url":null,"abstract":"<div><div>Enzalutamide (formerly called MDV3100), a second-generation androgen receptor inhibitor primarily used for treating castration-resistant prostate cancer (CRPC), has been shown to regulating UDP-glucuronosyltransferases (UGTs) expression, while its effects on the activity of UGT isoforms remain unclear. This study aimed to systemically investigate the effects of enzalutamide and its phase I metabolite on the UGT activities, and to assess the risk of drug-drug interactions (DDIs) resulting from UGT inhibition. Using high-performance liquid chromatography (HPLC) and enzyme kinetic studies, we evaluated the inhibitory effects of enzalutamide and its main phase I metabolite, N-desmethyl enzalutamide on 12 UGT isoforms and inhibition patterns. Our findings demonstrated that both enzalutamide and its metabolite exhibited potent inhibition against UGT1A1, with evidence of synergistic effects. Enzyme kinetic analysis revealed that both enzalutamide and its metabolite acted as competitive inhibitors of UGT1A1. In vitro-in vivo extrapolation (IVIVE) prediction indicated that concomitant use of enzalutamide with UGT1A1 substrates could induce clinically significant DDIs. Therefore, special caution should be warranted when administering enzalutamide alongside other drugs metabolized by UGT to mitigate potential DDIs.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111829"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145527626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia” [Chem. Biol. Interact. 418 (2025) 111606] 对社区获得性肺炎中对氧磷酶1相关变量和炎症标志物的诊断和预后价值的见解的更正[化学]。医学杂志。[互动]. 418 (2025)111606]
IF 5.4 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-05 Epub Date: 2025-11-08 DOI: 10.1016/j.cbi.2025.111808
Frederic Ballester , Xavier Gabaldó-Barrios , Andrea Jiménez-Franco , Isabel Pujol , Simona Iftimie , Jordi Camps , Sandra Parra , Antoni Castro , Jorge Joven
{"title":"Corrigendum to “Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia” [Chem. Biol. Interact. 418 (2025) 111606]","authors":"Frederic Ballester ,&nbsp;Xavier Gabaldó-Barrios ,&nbsp;Andrea Jiménez-Franco ,&nbsp;Isabel Pujol ,&nbsp;Simona Iftimie ,&nbsp;Jordi Camps ,&nbsp;Sandra Parra ,&nbsp;Antoni Castro ,&nbsp;Jorge Joven","doi":"10.1016/j.cbi.2025.111808","DOIUrl":"10.1016/j.cbi.2025.111808","url":null,"abstract":"","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"423 ","pages":"Article 111808"},"PeriodicalIF":5.4,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145464978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chemico-Biological Interactions
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1